Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

William J. Marks, Jill L. Ostrem, Leonard Verhagen, Philip A. Starr, Paul S. Larson, Roy AE Bakay, Robin Taylor, Deborah Cahn-Weiner, A. Jon Stoessl, C. Warren Olanow, Raymond T. Bartus

Research output: Contribution to journalArticlepeer-review

453 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial'. Together they form a unique fingerprint.

Medicine & Life Sciences